Safety profile of anifrolumab in patients with active SLE: an integrated analysis of phase II and III trials

by Eric F Morand, M Alex Michaels
Published 2021-09-01

Annexin I and dexamethasone effects on phospholipase and cyclooxygenase activity in human synoviocytes

by Annaleise V. Sampey, Paul Hutchinson, Eric F. Morand
Published 2000-01-01

Could GILZ Be the Answer to Glucocorticoid Toxicity in Lupus?

by Jacqueline K. Flynn, Wendy Dankers, Eric F. Morand
Published 2019-07-01

Regulation of Annexin I in Rheumatoid Synovial Cells by Glucocorticoids and Interleukin-1

by Eric F. Morand, Pam Hall, Paul Hutchinson, Yuan H. Yang
Published 2006-01-01

1401 Effects of anifrolumab on renal disease in patients with systemic lupus erythematosus

by Raj Tummala, Richard A Furie, Eric F Morand, Gabriel Abreu, Catharina Lindholm
Published 2021-11-01

P54 Screening for primary aldosteronism in hypertensive patients with systemic lupus erythematosus: are we doing it enough?

by Fabien B Vincent, Alberta Y Hoi, Eric F Morand, Jun Yang, Matthew Wong, Joanna R Kent
Published 2024-03-01

Clinical associations of cognitive dysfunction in systemic lupus erythematosus

by Rangi Kandane-Rathnayake, Eric F Morand, Vera Golder, Alberta Hoi, Sudha Raghunath, Julie C Stout, Yifat Glikmann-Johnston
Published 2023-02-01

Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus

by Fabien B Vincent, Alberta Y Hoi, Fabienne Mackay, James Harris, Rangi Kandane-Rathnayake, Eric F Morand, Rachel Koelmeyer
Published 2020-12-01

1502 Lupus low disease activity state attainment in the phase 3 placebo-controlled TULIP long-term extension trial of anifrolumab

by Richard A Furie, Eric F Morand, Sule Yavuz, Kenneth C Kalunian, Gabriel Abreu, Ronald van Vollenhoven, Catharina Lindholm, Hussein Al-Mossawi
Published 2024-05-01

Novel Methods of Incorporating Time in Longitudinal Multivariate Analysis Reveals Hidden Associations With Disease Activity in Systemic Lupus Erythematosus

by Hieu T. Nim, Hieu T. Nim, Kathryn Connelly, Fabien B. Vincent, François Petitjean, Alberta Hoi, Rachel Koelmeyer, Sarah E. Boyd, Eric F. Morand
Published 2019-07-01

Machine learning applied to whole‐blood RNA‐sequencing data uncovers distinct subsets of patients with systemic lupus erythematosus

by William A Figgett, Katherine Monaghan, Milica Ng, Monther Alhamdoosh, Eugene Maraskovsky, Nicholas J Wilson, Alberta Y Hoi, Eric F Morand, Fabienne Mackay
Published 2019-01-01

Immunosuppressant exposure confounds gene expression analysis in systemic lupus erythematosus

by Melissa Northcott, Linden J. Gearing, Linden J. Gearing, Julie Bonin, Rachel Koelmeyer, Alberta Hoi, Paul J. Hertzog, Paul J. Hertzog, Eric F. Morand
Published 2022-08-01

Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus

by Rachel Mende, Fabien B. Vincent, Rangi Kandane-Rathnayake, Rachel Koelmeyer, Emily Lin, Janet Chang, Alberta Y. Hoi, Eric F. Morand, James Harris, Tali Lang
Published 2018-06-01

Identifying lupus Patient Subsets Through Immune Cell Deconvolution of Gene Expression Data in Two Atacicept Phase II Studies

by Matthew Studham, Cristina Vazquez‐Mateo, Eileen Samy, Philipp Haselmayer, Aida Aydemir, P. Alexander Rolfe, Joan T. Merrill, Eric F. Morand, Julie DeMartino, Amy Kao, Robert Townsend
Published 2023-10-01

Targeting DORIS Remission and LLDAS in SLE: A Review

by Agner R. Parra Sánchez, Ronald F. van Vollenhoven, Eric F. Morand, Ian N. Bruce, Rangi Kandane-Rathnayake, Gudrun Weiss, Raj Tummala, Hussein Al-Mossawi, Alessandro Sorrentino
Published 2023-10-01

Pro-inflammatory action of MIF in acute myocardial infarction via activation of peripheral blood mononuclear cells.

by David A White, Lu Fang, William Chan, Eric F Morand, Helen Kiriazis, Stephen J Duffy, Andrew J Taylor, Anthony M Dart, Xiao-Jun Du, Xiao-Ming Gao
Published 2013-01-01

Correction: Pro-Inflammatory Action of MIF in Acute Myocardial Infarction via Activation of Peripheral Blood Mononuclear Cells.

by David A. White, Lu Fang, William Chan, Eric F. Morand, Helen Kiriazis, Stephen J. Duffy, Andrew J. Taylor, Anthony M. Dart, Xiao-Jun Du, Xiao-Ming Gao
Published 2013-01-01

LP-183 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and phase II study design in patients with SLE and/or CLE (WILLOW)

by Victoria P Werth, Eric F Morand, Melinda Przetak, Flavie Moreau, Cristina Vazquez-Mateo, Andrew Bender, Sanjeev Roy, Aditee Deshpande, Ankita Deshmukh, Bharat Vaidyanathan, Mukhy Khursheed, David R Pearson
Published 2023-07-01

1501 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and Phase II study design in patients with SLE and/or CLE (WILLOW)

by Victoria P Werth, Eric F Morand, Melinda Przetak, Flavie Moreau, Cristina Vazquez-Mateo, Andrew Bender, Sanjeev Roy, Aditee Deshpande, Ankita Deshmukh, Bharat Vaidyanathan, Mukhy Khursheed, David R Pearson
Published 2022-12-01

LP-184 Rationale and design of two phase 3, Randomized, double-blind, placebo-controlled studies of the efficacy and safety of litifilimab in adults with active systemic lupus eryt...

by Richard A Furie, Kenneth Kalunian, Maria Dall’Era, Eric F Morand, Puja Joshi, Ting Wang, Xing Wei, Catherine Barbey, Ronald FVan Vollenhoven, Stacey Goode-sellers, George Kong, Youmna Lahoud
Published 2023-07-01